ArticleNature communications2018

CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I.

Nerea Zabaleta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.